Antonio Passaro, Medical Oncologist and a Medical Director with High Specialization Assignment at the European Institute of Oncology, shared a post on X:
“A very interesting signal emerging from ESMO Asia25…
The COCOON Substudy suggests that simple, targeted skin management with 0.1% tacrolimus may help patients on 1L ami/laz maintain treatment smoothly, with early and encouraging improvements in dermatologic AEs.”
More posts featuring Antonio Passaro.